Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Recent & Breaking News (TSX:ONC)

Oncolytics Biotech® Inc. Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers

PR Newswire November 21, 2013

Oncolytics Biotech® Inc. Collaborators Present Positive Data Correlating Specific Biomarkers with Survival in NSCLC Patients Treated with REOLYSIN®, Carboplatin and Paclitaxel

Canada NewsWire October 28, 2013

Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer

Canada NewsWire October 22, 2013

Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer

Canada NewsWire October 1, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on ONCY, RMTI, TEVA and VPHM

Accesswire September 16, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY

Accesswire September 10, 2013

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Canada NewsWire September 9, 2013

Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer

Canada NewsWire September 9, 2013

Media Advisory - Oncolytics Biotech® Inc. to Present at the 2013 Wedbush PacGrow Life Sciences Management Access Conference

Canada NewsWire August 13, 2013

Oncolytics Biotech(R) Inc. Announces Second Quarter 2013 Results

Canada NewsWire August 1, 2013

Oncolytics Biotech® Inc. to Present at 2013 Jefferies Global Healthcare Conference

Canada NewsWire June 4, 2013

Oncolytics Biotech® Inc. to Present at 2013 Jefferies Global Healthcare Conference

PR Newswire June 4, 2013

Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report

Marketwired May 23, 2013

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial

Canada NewsWire May 22, 2013

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial

PR Newswire May 22, 2013

Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference

PR Newswire May 14, 2013

Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care Conference

Canada NewsWire May 14, 2013

Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders

Canada NewsWire May 10, 2013

Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of Shareholders

PR Newswire May 10, 2013

Oncolytics Biotech® Inc. Announces First Quarter 2013 Results

Canada NewsWire May 9, 2013